Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Prasgurel Versus Clopidogrel on the Dual Antiplatelet Regimen for Intracranial Stenting or Flow Diverter Treatment for Unruptured Cerebral Aneurysms: a Multi-center Randomized Controlled Trial

NCT05359224 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05359224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05359224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Prasgurel Versus Clopidogrel on the Dual Antiplatelet Regimen for Intracranial Stenting or Flow Diverter Treatment for Unruptured Cerebral Aneurysms: a Multi-center Randomized Controlled Trial
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Unknown status
Start date
June 13, 2022
Completion date
August 31, 2025
Enrollment
406 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm